Group 1 - The company, Shanghai Jianda Zhixin Medical Technology Group Co., Ltd., has issued a voluntary performance forecast for the fiscal year 2025, indicating that the net profit attributable to shareholders is expected to be positive and show an upward trend [1][3] - The performance forecast period is from January 1, 2025, to December 31, 2025 [1] - The company has communicated with its auditing firm regarding the performance forecast, and there are no discrepancies between the company and the auditors [2] Group 2 - The company's medical consumables centralized operation (SPD) business is experiencing rapid growth, contributing to an increase in overall profitability due to its high gross profit margin [3] - The company has optimized its financial structure, resulting in a year-on-year decrease in interest-bearing debt and a reduction in financing costs through negotiations with financial institutions, positively impacting net profit [3]
上海建发致新医疗科技集团 股份有限公司2025年度业绩预告